- Bayer (OTCPK:BAYRY), responding to Monsanto's (NYSE:MON) earlier rejection of its $62B takeover offer, says it "remains committed to working together" to complete the deal and is "confident that we can address any potential financing or regulatory [concerns]" raised by MON.
- MON said earlier it regarded Bayer's $122/share offer as too low, but that it respects Buyer's business and believes in the potential benefits of a merger.
- MON "does not want to be acquired," but may give into pressure from its shareholders and accept an offer over $140/share, Bernstein analyst Jonas Oxgaard contends, while any deal below $140 is "reasonable" from Bayer's perspective, Deutsche Bank's Tim Race says.